SB
JAZZ icon

Suntrust Banks’s Jazz Pharmaceuticals JAZZ Stock Holding History

Suntrust Banks’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$3.74M Buy
29,167
+3,780
+15% +$507K 0.02% 406
2019
Q2 		$3.62M Sell
25,387
-152
-0.6% -$20.4K 0.02% 420
2019
Q1 		$3.65M Buy
25,539
+5,837
+30% +$761K 0.02% 403
2018
Q4 		$2.44M Buy
19,702
+8,463
+75% +$1.26M 0.01% 475
2018
Q3 		$1.89M Sell
11,239
-1,672
-13% -$288K 0.01% 571
2018
Q2 		$2.23M Buy
12,911
+843
+7% +$138K 0.01% 521
2018
Q1 		$1.82M Buy
12,068
+902
+8% +$132K 0.01% 557
2017
Q4 		$1.5M Sell
11,166
-5,927
-35% -$822K 0.01% 607
2017
Q3 		$2.5M Buy
17,093
+100
+0.6% +$15.1K 0.01% 461
2017
Q2 		$2.64M Buy
16,993
+6,800
+67% +$1.04M 0.02% 424
2017
Q1 		$1.48M Buy
+10,193
New +$1.33M 0.01% 550
2016
Q2 		– Sell
-2,919
Closed -$381K – 1522
2016
Q1 		$381K Sell
2,919
-17,062
-85% -$2.12M ﹤0.01% 1028
2015
Q4 		$2.81M Sell
19,981
-1,313
-6% -$182K 0.02% 362
2015
Q3 		$2.83M Sell
21,294
-12,293
-37% -$2.12M 0.02% 344
2015
Q2 		$5.91M Sell
33,587
-987
-3% -$177K 0.04% 239
2015
Q1 		$5.97M Buy
34,574
+1,597
+5% +$274K 0.04% 239
2014
Q4 		$5.4M Sell
32,977
-5,226
-14% -$867K 0.04% 238
2014
Q3 		$6.13M Sell
38,203
-2,260
-6% -$347K 0.04% 227
2014
Q2 		$5.95M Buy
40,463
+74
+0.2% +$10.3K 0.04% 244
2014
Q1 		$5.6M Sell
40,389
-1,760
-4% -$265K 0.02% 435
2013
Q4 		$5.33M Sell
42,149
-8,585
-17% -$888K 0.02% 442
2013
Q3 		$4.67M Sell
50,734
-918
-2% -$74.1K 0.02% 447
2013
Q2 		$3.55M Buy
+51,652
New +$3.16M 0.02% 479

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Suntrust Banks's JAZZ Position: Q3 2019 in Review

Suntrust Banks increased its Jazz Pharmaceuticals (JAZZ) stake by 15% in Q3 2019, buying an estimated $507K and bringing the position to 29,167 shares worth $3.74M. The position accounts for 0.02% of the portfolio, ranked #406.

Suntrust Banks first reported a position in JAZZ in Q2 2013 and has held it in 23 quarters since. The position peaked at $6.13M in Q3 2014. 406 funds tracked by Wall St. Rank hold JAZZ as of Q3 2019.

  • Suntrust Banks held 29,167 shares of Jazz Pharmaceuticals worth $3.74M as of Q3 2019.
  • Suntrust Banks bought 3,780 Jazz Pharmaceuticals shares in Q3 2019, an estimated $507K.
  • Jazz Pharmaceuticals made up 0.02% of Suntrust Banks's portfolio in Q3 2019, its #406 holding.
  • Suntrust Banks first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 23 quarters since.
  • Suntrust Banks's Jazz Pharmaceuticals position peaked at $6.13M in Q3 2014.
  • 406 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2019.

Based on Suntrust Banks's 13F filing for Q3 2019, filed 12 Nov 2019.